How Many Weight Loss Injections Do You Need?

Both licensed UK weight loss injections (Mounjaro and Wegovy) are once-weekly subcutaneous injections; there is no single course with a fixed endpoint.
Treatment typically starts at the lowest dose to let your body adjust, then titrates upward every four weeks or so under prescriber guidance.
Clinical evidence, including the SURMOUNT-1 and STEP 1 trials, was collected over 68 to 72 weeks — so meaningful results take time, not a handful of injections.
Stopping and restarting requires clinical reassessment; the decision on duration belongs to you and your prescriber together, not a standard schedule.

There is no fixed total. Weight loss injections such as Mounjaro (tirzepatide) and Wegovy (semaglutide) are taken once a week, every week, for as long as treatment is clinically appropriate — which for most people means many months or longer. The number you need is not counted in advance; it is reviewed by your prescriber as your weight, health and response evolve. These are prescription-only medicines: a GPhC-registered Independent Prescriber assesses whether treatment is right for you before anything is dispensed. Understanding how often weight loss injections are taken is the first step to understanding the full picture.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

The truth about treatment length, titration and what to expect week by week

The myth: a short course of injections does the job

This is probably the most common misunderstanding about GLP-1 medicines. Many people approach Mounjaro or Wegovy the way they would antibiotics, a defined run, then done. That is not how they work. Both medicines act on appetite-regulating receptors while you are taking them. When you stop, those effects wind down, which is why clinical guidance consistently frames these as long-term treatments rather than short courses.

The SURMOUNT-1 trial, which formed the basis for Mounjaro's UK licence, ran for 72 weeks. Participants who lost substantial weight during that period and then stopped regained a significant portion of it in follow-up studies. The question of how long you need to take weight loss injections has a similarly nuanced answer: the honest response is that most people who benefit do so over a year or more, not over six or eight injections.

None of this means you are committed to treatment indefinitely. Your prescriber reviews your progress before every repeat, and stopping is always a clinical conversation, never a default. But going in expecting a short, finite course tends to lead to disappointment, or to stopping prematurely before a therapeutic dose has had a chance to work.

How the injection count actually builds up: titration in practice

Licensed UK weight loss injections follow a gradual dose-escalation schedule set by the prescriber. Mounjaro starts at 2.5 mg, a dose designed to let your digestive system settle in, not yet to produce significant weight loss. From there, the dose typically steps up every four weeks: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and up to 15 mg if tolerated. That is up to six months of titration before you reach the maximum maintenance dose, which means at least 24 weekly injections before you are even there.

Wegovy (semaglutide) follows a comparable escalation: 0.25 mg, 0.5 mg, 1.0 mg, 1.7 mg, and 2.4 mg, with a higher 7.2 mg dose now also approved by the MHRA. Again, this plays out over roughly five months of weekly injections. You can read more about what weight loss injection options exist in the UK if you are still deciding which suits your situation.

Practically speaking: the injection you do on a Tuesday evening before the school run is the same pen you used the Tuesday before. The habit is the point. Consistency, across weeks and months, is what the evidence is built on. Using fresh needles each time and rotating your injection site keep the process comfortable and the medicine working as it should.

What shapes the total number you need?

Several things influence how many injections make up your treatment. Your starting BMI, your weight-related health conditions, how your body responds to each dose, and whether side effects prompt a slower titration all play a part. The NHS England guidance on weight management injections makes clear that treatment decisions (including duration) should be guided by clinical review, not a preset schedule.

NICE recommends reviewing progress at six months on the highest tolerated dose: if weight loss falls below 5%, the clinical picture changes. That review is part of how reputable services protect patients, not a bureaucratic hurdle. At nume, a prescriber reviews your case before every repeat order. No subscription auto-renews silently. Every pen comes after a real clinician has looked at your answers.

Cost is a practical consideration too, and understanding what weight loss injections cost in the UK helps you plan honestly. One transparent price covers consultation, prescription, and next-working-day delivery, no hidden charges added later.

If you are transferring from another provider or considering a dose change, evidence of your current treatment and recent weight is always part of the clinical review. That applies at every stage, not just the first pen.

When might you need fewer, or more?

Some people reach a stable, healthy weight at a maintenance dose and, in discussion with their prescriber, begin stepping down or spacing out treatment. Others find that the conditions driving their weight (sleep apnoea, blood pressure, blood sugar) improve enough to change what ongoing treatment looks like. There is no standard endpoint because there is no standard patient.

Conversely, people who pause treatment for surgery, illness or pregnancy (for whom these medicines are not recommended during pregnancy or while breastfeeding) typically restart from a lower dose; the total injection count resets. Your prescriber advises on this based on individual circumstances.

The NHS medicines page for tirzepatide covers missed doses and what to do, but changes to your schedule, pauses or restarts should always go through your prescriber and the Patient Information Leaflet, not a general guide. If you want to explore whether treatment fits your situation, checking the BMI criteria for weight loss injections is a useful starting point before a consultation.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions